Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma × Biomarkers × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Breast Neoplasms 6 Neoplasms 3 Lung Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion 1 Pituitary Diseases 1 Pituitary ACTH Hypersecretion 1 Obesity 1 Myasthenia Gravis 1 Motor Activity 1 Lymphoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Cyclophosphamide 272 Rituximab 243 Etoposide 136 Filgrastim 128 fludarabine phosphate 105 Cytarabine 98 Vincristine 97 Radiotherapy 96 Melphalan 95 Doxorubicin 90 Peripheral Blood Stem Cell Transplantation 82 Methotrexate 80 fludarabine 78 Prednisone 78 Busulfan 77 Tacrolimus 54 Whole-Body Irradiation 52 Mycophenolic Acid 52 Granulocyte Colony-Stimulating Factor 52 Dexamethasone 52 Antilymphocyte Serum 51 Carmustine 49 Cyclosporine 39 Lenalidomide 38 Methylprednisolone 37 Bortezomib 37 Bendamustine Hydrochloride 34 sargramostim 33 Stem Cell Transplantation 31 Ifosfamide 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01921998 2015-02-04

BioACT

The Christie NHS Foundation Trust

LymphoidSarcoma

Lymphoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡